Rajendran Lab
Research Areas
The crux of our translational research is exploring the potential of natural compounds and innovative therapies to treat colorectal & intestinal cancer in its early stages by targeting epigenetic pathways.
The Antibody and Biopharmaceuticals Core (ABC) provides customized monoclonal antibody services using hybridoma technology to cater to the unique requirements of various research programs.